Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Benzoyl Peroxide vs Clascoterone: Benzoyl Peroxide has the stronger overall evidence (9 vs 7/10); they're alternatives for clearer skin (acne) — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Benzoyl Peroxide wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Benzoyl Peroxide and Clascoterone have evidence — compare verdict strength side-by-side.
Topical OTC use. Benzoyl peroxide is used at 2.5-10% in gels, creams, and washes, applied to acne-prone areas once or twice daily; lower strengths (2.5-5%) are usually as effective as 10% with less irritation. There is no oral or systemic dose — it is not ingested. It is often combined with a retinoid (e.g. adapalene) for greater effect. This library does not provide an ingestion protocol.
any
Leave-on gel/cream (2.5-5%) or a fixed combination with a retinoid
Apply a thin layer of clascoterone 1% cream to the affected area twice daily, morning and evening, on clean dry skin
Morning and evening
Clascoterone 1% cream
Layering with other actives increases erythema, dryness and peeling. Local skin reactions already occur in roughly 18% of users on clascoterone alone.
Discuss with your healthcare provider before combining.
Throughout
4-12 weeks
Throughout
First weeks
immediate
12 weeks
12 weeks
1-4 weeks
Topical benzoyl peroxide for acne.
Cochrane Database Syst Rev (2020) · Systematic review
Pooled 120 RCTs (29,592 participants); BPO more effective than placebo/no treatment for participant-reported improvement (RR 1.27, 95% CI 1.12 to 1.45)
Efficacy of topical treatments for mild-to-moderate acne: A systematic review and meta-analysis of randomized control trials.
J Eur Acad Dermatol Venereol (2025) · Meta analysis
Network meta-analysis of 35 RCTs (33,472 participants) comparing nine topical acne agents
Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.
J Am Acad Dermatol (2007) · Rct · n=517
517 subjects randomized double-blind to adapalene-BPO, adapalene, BPO, or vehicle for 12 weeks
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials
JAMA Dermatol (2020) · Rct · n=1440
The pivotal registration trials: two identical phase 3 studies, 1440 patients randomised, conducted November 2015 to April 2018.
Efficacy and Safety of 1% Clascoterone Cream in Patients Aged > 12 Years With Acne Vulgaris
J Drugs Dermatol (2023) · Rct · n=1421
709 patients received clascoterone and 712 received vehicle in the pooled ≥12-year population.
Efficacy and safety of topical clascoterone cream for treatment of acne vulgaris: A systematic review and meta-analysis of randomized placebo-controlled trials
Dermatol Ther (2021) · Meta analysis · n=2457
Five trials, 2457 patients (1357 clascoterone, 1100 placebo), overall low risk of bias.
Benzoyl Peroxide has a higher evidence score (9/10 vs 7/10) and wins in 2 of 3 categories.
For clearer skin (acne), Clascoterone has a higher relevance score (92 vs 85).
Layering with other actives increases erythema, dryness and peeling. Local skin reactions already occur in roughly 18% of users on clascoterone alone. Discuss with your healthcare provider before combining. Consult a healthcare provider for personalized advice.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.